Autoimmune diseases are a pathophysiological state wherein immune responses are directed against, and damage, the body's own tissues (autoimmunity). Common examples of autoimmune disease include ...

Immunosuppressive treatment is considered for autoimmune, inflammatory and lymphoproliferative disorders that frequently develop in CVID. Bronchopulmonary hygiene measures and pulmonary ...

It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes in which there is an existence of occult abnormal B-cell, T-cell or NK-cell clones.

Calquence is under clinical development by AstraZeneca and currently in Phase III for Follicular Lymphoma. According to GlobalData, Phase III drugs for Follicular Lymphoma have a 55% phase transition ...

Calquence is under clinical development by AstraZeneca and currently in Phase II for Anti-MAG Peripheral Neuropathy.

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in early January 2025 and will be priced at parity to the IV version of ...

After hours: December 27 at 5:55:55 p.m. EST ...